Strategic Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Strategic Wealth Partners's ELV Position: Q2 2026 in Review
Strategic Wealth Partners reduced its Elevance Health (ELV) stake by 2.2% in Q2 2026, selling an estimated $3.71K and leaving 448 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #330.
Strategic Wealth Partners first reported a position in ELV in Q2 2018 and has held it in 20 quarters since. The position peaked at $3.7M in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Strategic Wealth Partners held 448 shares of Elevance Health worth $173K as of Q2 2026.
- Strategic Wealth Partners sold 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
- Elevance Health made up 0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #330 holding.
- Strategic Wealth Partners first reported a position in Elevance Health in Q2 2018 and has held it in 20 quarters since.
- Strategic Wealth Partners's Elevance Health position peaked at $3.7M in Q2 2024.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.